(Q33990770)

30 July 2017

0 references

1 reference

title

Antidepressants and their effect on sleep (English)

1 reference

30 July 2017

Andrew G Mayers

1

0 references

author name string

David S Baldwin

series ordinal

2

1 reference

30 July 2017

publication date

1 December 2005

1 reference

30 July 2017

published in

Human Psychopharmacology

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

533-559

1 reference

Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report

30 July 2017

cites work

1 reference

Trazodone for antidepressant-associated insomnia.

21 January 2018

1 reference

A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

21 January 2018

1 reference

A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance

21 January 2018

1 reference

Total prolonged drug-induced REM sleep suppression in anxious-depressed patients.

21 January 2018

1 reference

Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression

21 January 2018

1 reference

7 January 2021

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

1 reference

7 January 2021

A Multicenter, Double-Blind Comparison of the Effects of Nefazodone and Fluoxetine on Sleep Architecture and Quality of Sleep in Depressed Outpatients

1 reference

7 January 2021

Zolpidem for persistent insomnia in SSRI-treated depressed patients

1 reference

7 January 2021

Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action

1 reference

7 January 2021

Depressed in-patients respond differently to imipramine and mirtazapine

1 reference

7 January 2021

Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia

1 reference

7 January 2021

The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine

1 reference

7 January 2021

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

1 reference

7 January 2021

A double-blind comparison of paroxetine and placebo in the treatment of depressed outpatients

1 reference

7 January 2021

Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison

1 reference

7 January 2021

Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects

1 reference

7 January 2021

A comparison of paroxetine and placebo in depressed outpatients

1 reference

7 January 2021

A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes

1 reference

7 January 2021

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

1 reference

7 January 2021

A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression

1 reference

7 January 2021

Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia.

1 reference

7 January 2021

Predictors of an acute antidepressant response to fluoxetine and sertraline

1 reference

7 January 2021

Monoamine oxidase inhibitor-responsive depression.

1 reference

7 January 2021

Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers

1 reference

7 January 2021

A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.

1 reference

7 January 2021

Depression and anxiety: mianserin and nomifensine compared in a double-blind multicentre trial.

1 reference

7 January 2021

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features

1 reference

7 January 2021

The role of histamine and the tuberomamillary nucleus in the nervous system

1 reference

7 January 2021

Nocturnal Melatonin Secretion and Sleep after Doxepin Administration in Chronic Primary Insomnia

1 reference

7 January 2021

Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study

1 reference

7 January 2021

A rating scale for depression

1 reference

7 January 2021

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

1 reference

7 January 2021

Bupropion SR worsens mood during marijuana withdrawal in humans

1 reference

7 January 2021

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

1 reference

7 January 2021

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression

1 reference

7 January 2021

Pharmacodynamics of milnacipran in young and elderly volunteers

1 reference

7 January 2021

Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study.

1 reference

7 January 2021

Effects of sertraline on sleep architecture in patients with depression

1 reference

7 January 2021

Effects of fluoxetine on psychomotor performance, cognitive function and sleep in depressed patients

1 reference

7 January 2021

Low-dose amitriptyline as an adjunct to opioids for postoperative orthopedic pain: a placebo-controlled trial

1 reference

7 January 2021

1 reference

7 January 2021

Reboxetine induces similar sleep-EEG changes like SSRI's in patients with depression

1 reference

7 January 2021

REM sleep and central monoamine oxidase inhibition

1 reference

7 January 2021

Fluvoxamine versus desipramine: comparative polysomnographic effects.

1 reference

7 January 2021

A new look at erythromycin

1 reference

7 January 2021

The effect of escitalopram on sleep problems in depressed patients

1 reference

7 January 2021

A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers.

1 reference

7 January 2021

Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations

1 reference

7 January 2021

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

1 reference

7 January 2021

A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder

1 reference

7 January 2021

Subjective and polysomnographic effects of milnacipran on sleep in depressed patients

1 reference

7 January 2021

A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression

1 reference

7 January 2021

Mianserin is better tolerated and more effective in depression than a nomifensine-clobazam combination: a double-blind study.

1 reference

7 January 2021

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression

1 reference

7 January 2021

Effects of mianserin on human sleep.

1 reference

7 January 2021

Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent

1 reference

7 January 2021

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.

1 reference

7 January 2021

Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression

1 reference

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

7 January 2021

Effects of trazodone on the sleep of depressed subjects--a polygraphic study.

1 reference

7 January 2021

Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants

1 reference

7 January 2021

Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.

1 reference

7 January 2021

Effect of bupropion-SR on REM sleep: relationship to antidepressant response

1 reference

7 January 2021

Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers

1 reference

7 January 2021

Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens

1 reference

7 January 2021

Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo

1 reference

7 January 2021

Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation.

1 reference

7 January 2021

A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.

1 reference

7 January 2021

Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study

1 reference

7 January 2021

Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers

1 reference

7 January 2021

Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study.

1 reference

7 January 2021

Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor

1 reference

7 January 2021

Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder

1 reference

7 January 2021

Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects

1 reference

7 January 2021

1 reference

7 January 2021

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients

1 reference

7 January 2021

A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients

1 reference

7 January 2021

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial

1 reference

7 January 2021

The effect of bupropion on nicotine craving and withdrawal

1 reference

7 January 2021

Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients.

1 reference

7 January 2021

Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison.

1 reference

7 January 2021

A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression

1 reference

7 January 2021

Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression

1 reference

7 January 2021

The impact of antidepressants on sleep and anxiety: a comparative study of fluoxetine and dothiepin using the Leeds Sleep Evaluation Questionnaire

1 reference

7 January 2021

The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers.

1 reference

7 January 2021

Trazodone for deafferentation pain. Comparison with amitriptyline.

1 reference

7 January 2021

Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.

1 reference

7 January 2021

Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?

1 reference

7 January 2021

24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder

1 reference

7 January 2021

Brofaromine versus imipramine in in-patients with major depression--a controlled trial

1 reference

7 January 2021

Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients

1 reference

7 January 2021

The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.

1 reference

7 January 2021

Antidepressants and sleep: a qualitative review of the literature

1 reference

7 January 2021

Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers

1 reference

7 January 2021

Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood.

1 reference

7 January 2021

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia

1 reference

7 January 2021

Depression, sleep physiology, and antidepressant drugs

1 reference

7 January 2021

Differential effects of trimipramine and fluoxetine on sleep in geriatric depression

1 reference

7 January 2021

A double-blind placebo controlled trial of fluoxetine in fibromyalgia

1 reference

7 January 2021

Low dose amitriptyline in chronic pain: the gain is modest.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.726

1 reference

30 July 2017

1 reference